Endo dismisses lawsuit against the FDA after two-year battle
September 30, 2019 at 11:50 AM EDT
The two-year court battle centered on the bulk compounding of the active ingredient in Endo's blood pressure medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|